Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate

Mycoses

Volumn 49, Issue 3, 2006, Pages 242-245

  Yalaz, Mehmet ^a   Akisu, Mete ^a   Hilmioglu, Suleyha ^a   Calkavur, Sebnem ^a   Cakmak, Bilin ^a   Kultursay, Nilgun ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Caspofungin; Fungus; Newborn; Septicaemia; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE;

ARTICLE; CANDIDA PARAPSILOSIS; CANDIDIASIS; CASE REPORT; CONGENITAL INFECTION; DRUG EFFICACY; EXTREMELY LOW BIRTH WEIGHT; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEWBORN; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MULTIPLE, FUNGAL; FEMALE; FUNGEMIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MALE; PEPTIDES, CYCLIC; PREGNANCY; TREATMENT OUTCOME;

CANDIDA; CANDIDA PARAPSILOSIS; FUNGI;

EID: 33646258509     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01220.x     Document Type: Article

References (23)

1. Cole FS. Infections and immunologic defence mechanism: fungal infections In Taeusch HW Ballard A eds Avery's Disease of The Newborn 7th edn Philadelphia WB Saunders Co. 1998 520 7
2. Saiman L Ludington E Pfaller M et al. Risk factors for candidaemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group Pediatr Infect Dis J 2000 19 319 24
3. Arai H Goto R Matsuda T et al. Case of congenital infection with Candida glabrata in one infant in a set of twins Pediatr Int 2002 44 449 50
4. Dutta S Narang A. Drug resistant neonatal Candida tropicalis septicaemia. Did it cause diaphragmatic hernia? Indian Pediatr 2003 40 261 4
5. Frattarelli DA Reed MD Giacoia GP Aranda JV. Antifungals in systemic neonatal candidiasis Drugs 2004 64 949 68
6. Maschmeyer G Ruhnke M. Update on antifungal treatment of invasive Candida and Aspergillus infections Mycoses 2004 47 263 76
7. Chapman RL. Candida infections in the neonate Curr Opin Pediatr 2003 15 97 102
8. Elanjikal Z Sorensen J Schmidt H et al. Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis Pediatr Infect Dis J 2003 22 653 6
9. Hesseling M Weindling M Neal T. First reported use of caspofungin in an extremely low-birth-weight neonate J Matern Fetal Neonatal Med 2003 14 212
10. Pradeepkumar VK Rajadurai VS Tan KW. Congenital candidiasis: varied presentations J Perinatol 1998 18 311 6
11. Darmstadt GL Dinulos JG Miller Z. Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines Pediatrics 2000 105 438 44
12. Whyte RK Hussain Z de Sa D. Antenatal infections with Candida species Arch Dis Child 1982 57 528 35
13. Frezza S Maggio L De Carolis MP et al. Risk factors for pulmonary candidiasis in preterm infants with a birth weight of less than 1250 g Eur J Pediatr 2005 164 88 92
14. National Committee for Clinical Laboratory Standards Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A Wayne, PA National Committee for Clinical Laboratory Standards 1997
15. Arnavielhe S Blancard A Mallie M Bastide JM. Case report of three Candida albicans infections detected at delivery J Infect 2000 40 88 90
16. Rowen JL Tate JM Nordoff N Passarell L McGinnis MR. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility J Clin Microbiol 1999 37 3735 7
17. Abuhammour W Habte-Gaber E. Newer antifungal agents Indian J Pediatr 2004 71 253 9
18. Swinne D Watelle M Van der Flaes M Nolard N. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study) Mycoses 2004 47 177 83
19. Franklin JA McCormick J Flynn PM. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients Pediatr Infect Dis J. 2003 22 747 9
20. Juster-Reicher A Flidel-Rimon O Amitay M et al. High dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates Eur J Clin Microbiol Infect Dis 2003 22 603 7
21. Cuenca-Estrella M Rodriguez D Almirante B et al. Barcelona Candidemia Project Study Group In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003 J Antimicrob Chemother 2005 55 194 9
22. Keating GM Jarvis B. Caspofungin Drugs 2001 61 1121 9
23. Odio CM Araya R Pinto LE et al. Caspofungin therapy of neonates with invasive candidiasis Pediatr Infect Dis J. 2004 23 1093 7